Origin Therapeutics Holdings (XCNQ:ORIG) Price-to-Free-Cash-Flow : N/A (As of Jun. 09, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Origin Therapeutics Holdings Price-to-Free-Cash-Flow?

As of today (2024-06-09), Origin Therapeutics Holdings's share price is C$0.025. Origin Therapeutics Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 was C$-0.01. Hence, Origin Therapeutics Holdings's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for Origin Therapeutics Holdings's Price-to-Free-Cash-Flow or its related term are showing as below:

XCNQ:ORIG's Price-to-Free-Cash-Flow is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 22.85
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

Origin Therapeutics Holdings's Free Cash Flow per Share for the three months ended in Jun. 2023 was C$-0.01. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was C$-0.01.

Origin Therapeutics Holdings Price-to-Free-Cash-Flow Historical Data

The historical data trend for Origin Therapeutics Holdings's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Origin Therapeutics Holdings Price-to-Free-Cash-Flow Chart

Origin Therapeutics Holdings Annual Data

Trend

Sep21

Sep22

Price-to-Free-Cash-Flow

Origin Therapeutics Holdings Quarterly Data
	Mar21	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23
Price-to-Free-Cash-Flow	Get a 7-Day Free Trial				-	-	-	-	-

Competitive Comparison of Origin Therapeutics Holdings's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, Origin Therapeutics Holdings's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Origin Therapeutics Holdings's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Origin Therapeutics Holdings's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Origin Therapeutics Holdings's Price-to-Free-Cash-Flow falls into.

Origin Therapeutics Holdings Price-to-Free-Cash-Flow Calculation

Origin Therapeutics Holdings's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio	=	Share Price	/	Free Cash Flow per Share (TTM)
	=	0.025	/	-0.014
	=	N/A

Origin Therapeutics Holdings's Share Price of today is C$0.025.
Origin Therapeutics Holdings's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Jun. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was C$-0.01.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio

Market Cap

Free Cash Flow

Origin Therapeutics Holdings (XCNQ:ORIG) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.

Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.

Origin Therapeutics Holdings Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Origin Therapeutics Holdings's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.